COMPASS

AMCA’S

COMPASSIONATE

ACCESS SCHEME

CLINICIAN REGISTRATION FORM
DONATE STOCK

Although AMCA recognises that several companies in Australia that are providing compassionate access,

we see the need for a national scheme to provide a coordinated approach to build and distribute a larger

suppply to patients-in-need.

After an initial 6-month pilot, AMCA is excited to launch its national compassionate access scheme

(COMPASS) and invites ANY medicinal cannabis clinician to participate and ANY industry to donate goods

or funds to ensure supply for patients unable to afford their treatment.

We would like to sincerely thank our partners in this venture, especially Cannabis Warehouse that is not

profiting in any way from their philanthropic support for this project. Also, the many companies that are

donating stock; the many pharmacies, including Dispense Direct that are helping with distribution to

patients; and the prescribers who are putting patients in need in touch with us so we can help them.

PATIENTS: Please ask your clinician to register through the above link or to contact us if they wish to apply

for compassionate access for you.

CLINICIANS: Please click the CLINICIAN REGISTRATION FORM button above to register your details with

our distributor, Cannabis Warehouse. You will then receive an e-mail to make the application for your

patient. 

Please be assured that registering with Cannabis Warehouse for the COMPASS scheme will NOT expose

you to any unwanted marketing approachess or materials and your details will be treated as confidential.

INDUSTRY: Please register your expression of interest in being a COMPASS industry donor by clicking on

the DONATE STOCK button above or the form below these already participating companies:

BACKGROUND TO COMPASS

In November 2022, a group of AMCA Board Directors and Ambassadors visited the Hon Mark Butler to

request seed funding to enable the national COMPASS compassionate access scheme to start.

Unfortunately, although we were encouraged by that meeting, the Minister failed to provide for such

funding in the May 2023 budget. AMCA received a formal letter declining funding and replied to him.

Links to the two letters are below:

We shall continue to work with the Parliamentary Friends of Medicinal Cannabis (PFMC) to lobby the

government to support what the government was asked to do in the report of the Senate Inquiry of 2020.

Please click the button below to see the full Senate Inquiry 2020 report. In the meantime, we are delighted

to have found valued and generous partners that have made it possible for AMCA to go ahead with a

national compassionate access program, despite the lack of government funding.

Senate Inquiry 2020 report